nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—Suicide—Sorafenib—liver cancer	0.0107	0.0657	CcSEcCtD
Metoclopramide—Completed suicide—Sorafenib—liver cancer	0.00943	0.058	CcSEcCtD
Metoclopramide—Gynaecomastia—Sorafenib—liver cancer	0.00496	0.0305	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Sorafenib—liver cancer	0.00444	0.0273	CcSEcCtD
Metoclopramide—Neutropenia—Sorafenib—liver cancer	0.00325	0.02	CcSEcCtD
Metoclopramide—Erectile dysfunction—Sorafenib—liver cancer	0.0032	0.0197	CcSEcCtD
Metoclopramide—Jaundice—Sorafenib—liver cancer	0.00302	0.0186	CcSEcCtD
Metoclopramide—Flushing—Sorafenib—liver cancer	0.00258	0.0159	CcSEcCtD
Metoclopramide—Blood disorder—Epirubicin—liver cancer	0.00245	0.0151	CcSEcCtD
Metoclopramide—Delirium—Epirubicin—liver cancer	0.00238	0.0146	CcSEcCtD
Metoclopramide—Amenorrhoea—Epirubicin—liver cancer	0.00233	0.0143	CcSEcCtD
Metoclopramide—Muscle spasms—Sorafenib—liver cancer	0.00233	0.0143	CcSEcCtD
Metoclopramide—Blood disorder—Doxorubicin—liver cancer	0.00227	0.014	CcSEcCtD
Metoclopramide—Angioedema—Sorafenib—liver cancer	0.00221	0.0136	CcSEcCtD
Metoclopramide—Delirium—Doxorubicin—liver cancer	0.0022	0.0135	CcSEcCtD
Metoclopramide—Dyskinesia—Epirubicin—liver cancer	0.00218	0.0134	CcSEcCtD
Metoclopramide—Leukopenia—Sorafenib—liver cancer	0.00217	0.0133	CcSEcCtD
Metoclopramide—Amenorrhoea—Doxorubicin—liver cancer	0.00216	0.0133	CcSEcCtD
Metoclopramide—Atrioventricular block—Epirubicin—liver cancer	0.00211	0.013	CcSEcCtD
Metoclopramide—Hypertension—Sorafenib—liver cancer	0.00209	0.0129	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Epirubicin—liver cancer	0.00205	0.0126	CcSEcCtD
Metoclopramide—Sunitinib—KDR—liver cancer	0.00205	1	CrCbGaD
Metoclopramide—Dyskinesia—Doxorubicin—liver cancer	0.00202	0.0124	CcSEcCtD
Metoclopramide—Atrioventricular block—Doxorubicin—liver cancer	0.00195	0.012	CcSEcCtD
Metoclopramide—Fluid retention—Epirubicin—liver cancer	0.00194	0.012	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Doxorubicin—liver cancer	0.0019	0.0117	CcSEcCtD
Metoclopramide—Rash maculo-papular—Epirubicin—liver cancer	0.00186	0.0114	CcSEcCtD
Metoclopramide—Fluid retention—Doxorubicin—liver cancer	0.0018	0.0111	CcSEcCtD
Metoclopramide—Dyspnoea—Sorafenib—liver cancer	0.00176	0.0108	CcSEcCtD
Metoclopramide—Rash maculo-papular—Doxorubicin—liver cancer	0.00172	0.0106	CcSEcCtD
Metoclopramide—Fatigue—Sorafenib—liver cancer	0.00171	0.0105	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Epirubicin—liver cancer	0.00164	0.0101	CcSEcCtD
Metoclopramide—Urticaria—Sorafenib—liver cancer	0.00157	0.00966	CcSEcCtD
Metoclopramide—Body temperature increased—Sorafenib—liver cancer	0.00156	0.00961	CcSEcCtD
Metoclopramide—Renal impairment—Epirubicin—liver cancer	0.00156	0.00961	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Doxorubicin—liver cancer	0.00152	0.00933	CcSEcCtD
Metoclopramide—Hypersensitivity—Sorafenib—liver cancer	0.00146	0.00896	CcSEcCtD
Metoclopramide—Renal impairment—Doxorubicin—liver cancer	0.00145	0.00889	CcSEcCtD
Metoclopramide—Asthenia—Sorafenib—liver cancer	0.00142	0.00872	CcSEcCtD
Metoclopramide—Cardiac arrest—Epirubicin—liver cancer	0.00141	0.00869	CcSEcCtD
Metoclopramide—Diarrhoea—Sorafenib—liver cancer	0.00135	0.00832	CcSEcCtD
Metoclopramide—Cardiac arrest—Doxorubicin—liver cancer	0.00131	0.00804	CcSEcCtD
Metoclopramide—Dizziness—Sorafenib—liver cancer	0.00131	0.00804	CcSEcCtD
Metoclopramide—Asthma—Epirubicin—liver cancer	0.00129	0.0079	CcSEcCtD
Metoclopramide—Rash—Sorafenib—liver cancer	0.00125	0.00767	CcSEcCtD
Metoclopramide—Dermatitis—Sorafenib—liver cancer	0.00125	0.00766	CcSEcCtD
Metoclopramide—Headache—Sorafenib—liver cancer	0.00124	0.00762	CcSEcCtD
Metoclopramide—Neutropenia—Epirubicin—liver cancer	0.0012	0.00739	CcSEcCtD
Metoclopramide—Asthma—Doxorubicin—liver cancer	0.00119	0.00731	CcSEcCtD
Metoclopramide—Pollakiuria—Epirubicin—liver cancer	0.00119	0.0073	CcSEcCtD
Metoclopramide—Nausea—Sorafenib—liver cancer	0.00117	0.00722	CcSEcCtD
Metoclopramide—Drowsiness—Epirubicin—liver cancer	0.00115	0.00705	CcSEcCtD
Metoclopramide—Jaundice—Epirubicin—liver cancer	0.00112	0.00687	CcSEcCtD
Metoclopramide—Neutropenia—Doxorubicin—liver cancer	0.00111	0.00684	CcSEcCtD
Metoclopramide—Pollakiuria—Doxorubicin—liver cancer	0.0011	0.00675	CcSEcCtD
Metoclopramide—Agranulocytosis—Epirubicin—liver cancer	0.00107	0.00657	CcSEcCtD
Metoclopramide—Drowsiness—Doxorubicin—liver cancer	0.00106	0.00652	CcSEcCtD
Metoclopramide—Bradycardia—Epirubicin—liver cancer	0.00105	0.00644	CcSEcCtD
Metoclopramide—Jaundice—Doxorubicin—liver cancer	0.00103	0.00635	CcSEcCtD
Metoclopramide—Visual impairment—Epirubicin—liver cancer	0.000991	0.0061	CcSEcCtD
Metoclopramide—Agranulocytosis—Doxorubicin—liver cancer	0.00099	0.00608	CcSEcCtD
Metoclopramide—Bradycardia—Doxorubicin—liver cancer	0.000969	0.00596	CcSEcCtD
Metoclopramide—Flushing—Epirubicin—liver cancer	0.000955	0.00587	CcSEcCtD
Metoclopramide—Visual impairment—Doxorubicin—liver cancer	0.000917	0.00564	CcSEcCtD
Metoclopramide—Flushing—Doxorubicin—liver cancer	0.000883	0.00543	CcSEcCtD
Metoclopramide—Nervousness—Epirubicin—liver cancer	0.00087	0.00535	CcSEcCtD
Metoclopramide—Muscle spasms—Epirubicin—liver cancer	0.000861	0.00529	CcSEcCtD
Metoclopramide—Agitation—Epirubicin—liver cancer	0.000823	0.00506	CcSEcCtD
Metoclopramide—Nervousness—Doxorubicin—liver cancer	0.000805	0.00495	CcSEcCtD
Metoclopramide—Leukopenia—Epirubicin—liver cancer	0.000802	0.00493	CcSEcCtD
Metoclopramide—Muscle spasms—Doxorubicin—liver cancer	0.000797	0.0049	CcSEcCtD
Metoclopramide—Palpitations—Epirubicin—liver cancer	0.000791	0.00487	CcSEcCtD
Metoclopramide—Convulsion—Epirubicin—liver cancer	0.000776	0.00477	CcSEcCtD
Metoclopramide—Hypertension—Epirubicin—liver cancer	0.000773	0.00475	CcSEcCtD
Metoclopramide—Agitation—Doxorubicin—liver cancer	0.000761	0.00468	CcSEcCtD
Metoclopramide—Anxiety—Epirubicin—liver cancer	0.00076	0.00467	CcSEcCtD
Metoclopramide—Leukopenia—Doxorubicin—liver cancer	0.000742	0.00456	CcSEcCtD
Metoclopramide—Confusional state—Epirubicin—liver cancer	0.000737	0.00453	CcSEcCtD
Metoclopramide—Palpitations—Doxorubicin—liver cancer	0.000732	0.0045	CcSEcCtD
Metoclopramide—Oedema—Epirubicin—liver cancer	0.000731	0.00449	CcSEcCtD
Metoclopramide—Convulsion—Doxorubicin—liver cancer	0.000718	0.00441	CcSEcCtD
Metoclopramide—Hypertension—Doxorubicin—liver cancer	0.000715	0.0044	CcSEcCtD
Metoclopramide—Tachycardia—Epirubicin—liver cancer	0.000713	0.00439	CcSEcCtD
Metoclopramide—Anxiety—Doxorubicin—liver cancer	0.000703	0.00432	CcSEcCtD
Metoclopramide—Hypotension—Epirubicin—liver cancer	0.000683	0.0042	CcSEcCtD
Metoclopramide—Confusional state—Doxorubicin—liver cancer	0.000682	0.00419	CcSEcCtD
Metoclopramide—Oedema—Doxorubicin—liver cancer	0.000676	0.00416	CcSEcCtD
Metoclopramide—Insomnia—Epirubicin—liver cancer	0.000661	0.00406	CcSEcCtD
Metoclopramide—Tachycardia—Doxorubicin—liver cancer	0.00066	0.00406	CcSEcCtD
Metoclopramide—Dyspnoea—Epirubicin—liver cancer	0.000652	0.00401	CcSEcCtD
Metoclopramide—Somnolence—Epirubicin—liver cancer	0.00065	0.00399	CcSEcCtD
Metoclopramide—Hypotension—Doxorubicin—liver cancer	0.000632	0.00389	CcSEcCtD
Metoclopramide—Fatigue—Epirubicin—liver cancer	0.00063	0.00387	CcSEcCtD
Metoclopramide—Insomnia—Doxorubicin—liver cancer	0.000612	0.00376	CcSEcCtD
Metoclopramide—Dyspnoea—Doxorubicin—liver cancer	0.000603	0.00371	CcSEcCtD
Metoclopramide—Feeling abnormal—Epirubicin—liver cancer	0.000602	0.0037	CcSEcCtD
Metoclopramide—Somnolence—Doxorubicin—liver cancer	0.000601	0.0037	CcSEcCtD
Metoclopramide—Fatigue—Doxorubicin—liver cancer	0.000583	0.00358	CcSEcCtD
Metoclopramide—Urticaria—Epirubicin—liver cancer	0.000581	0.00357	CcSEcCtD
Metoclopramide—Body temperature increased—Epirubicin—liver cancer	0.000578	0.00355	CcSEcCtD
Metoclopramide—Feeling abnormal—Doxorubicin—liver cancer	0.000557	0.00343	CcSEcCtD
Metoclopramide—Hypersensitivity—Epirubicin—liver cancer	0.000538	0.00331	CcSEcCtD
Metoclopramide—Urticaria—Doxorubicin—liver cancer	0.000537	0.0033	CcSEcCtD
Metoclopramide—Body temperature increased—Doxorubicin—liver cancer	0.000535	0.00329	CcSEcCtD
Metoclopramide—Asthenia—Epirubicin—liver cancer	0.000524	0.00322	CcSEcCtD
Metoclopramide—Diarrhoea—Epirubicin—liver cancer	0.0005	0.00307	CcSEcCtD
Metoclopramide—Hypersensitivity—Doxorubicin—liver cancer	0.000498	0.00306	CcSEcCtD
Metoclopramide—Asthenia—Doxorubicin—liver cancer	0.000485	0.00298	CcSEcCtD
Metoclopramide—Dizziness—Epirubicin—liver cancer	0.000483	0.00297	CcSEcCtD
Metoclopramide—Diarrhoea—Doxorubicin—liver cancer	0.000463	0.00284	CcSEcCtD
Metoclopramide—Rash—Epirubicin—liver cancer	0.000461	0.00283	CcSEcCtD
Metoclopramide—Dermatitis—Epirubicin—liver cancer	0.00046	0.00283	CcSEcCtD
Metoclopramide—Headache—Epirubicin—liver cancer	0.000458	0.00281	CcSEcCtD
Metoclopramide—Dizziness—Doxorubicin—liver cancer	0.000447	0.00275	CcSEcCtD
Metoclopramide—Nausea—Epirubicin—liver cancer	0.000434	0.00267	CcSEcCtD
Metoclopramide—Rash—Doxorubicin—liver cancer	0.000426	0.00262	CcSEcCtD
Metoclopramide—Dermatitis—Doxorubicin—liver cancer	0.000426	0.00262	CcSEcCtD
Metoclopramide—Headache—Doxorubicin—liver cancer	0.000424	0.0026	CcSEcCtD
Metoclopramide—Nausea—Doxorubicin—liver cancer	0.000402	0.00247	CcSEcCtD
Metoclopramide—DRD2—Signaling Pathways—CCR4—liver cancer	0.000233	0.000279	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CG—liver cancer	0.00023	0.000275	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN1B—liver cancer	0.000229	0.000275	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR4—liver cancer	0.000228	0.000273	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—liver cancer	0.000228	0.000273	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PRKCE—liver cancer	0.000227	0.000272	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—F2—liver cancer	0.000227	0.000272	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AKT1—liver cancer	0.000227	0.000272	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PSMD10—liver cancer	0.000226	0.000271	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PSMA4—liver cancer	0.000226	0.000271	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CASP3—liver cancer	0.000225	0.000269	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—liver cancer	0.000224	0.000269	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—liver cancer	0.000223	0.000267	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—liver cancer	0.000223	0.000267	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PRKCE—liver cancer	0.000222	0.000266	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PPARG—liver cancer	0.000222	0.000266	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CSF2—liver cancer	0.000221	0.000265	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000221	0.000264	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCND1—liver cancer	0.000219	0.000262	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PIK3CB—liver cancer	0.000219	0.000262	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JUN—liver cancer	0.000218	0.000261	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CG—liver cancer	0.000217	0.00026	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CTNNB1—liver cancer	0.000217	0.000259	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CSF2—liver cancer	0.000217	0.000259	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CD—liver cancer	0.000216	0.000259	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—liver cancer	0.000213	0.000255	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—liver cancer	0.000212	0.000254	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN1A—liver cancer	0.000212	0.000253	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000211	0.000253	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CPT1B—liver cancer	0.00021	0.000252	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GLUL—liver cancer	0.00021	0.000252	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAPK8—liver cancer	0.000207	0.000247	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AKT1—liver cancer	0.000206	0.000247	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—F2—liver cancer	0.000206	0.000247	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NR1H4—liver cancer	0.000203	0.000243	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CD—liver cancer	0.000202	0.000242	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CSF2—liver cancer	0.000201	0.000241	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—liver cancer	0.0002	0.000239	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTA3—liver cancer	0.000199	0.000239	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CG—liver cancer	0.000197	0.000236	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CSF2—liver cancer	0.000197	0.000235	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CD—liver cancer	0.000191	0.000229	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—liver cancer	0.000191	0.000228	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—STAT3—liver cancer	0.000189	0.000226	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CB—liver cancer	0.000188	0.000226	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADAM17—liver cancer	0.000184	0.000221	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTA4—liver cancer	0.000182	0.000218	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADAM17—liver cancer	0.00018	0.000216	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTA2—liver cancer	0.000178	0.000213	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CB—liver cancer	0.000176	0.000211	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MYC—liver cancer	0.000176	0.00021	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCE—liver cancer	0.000175	0.00021	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—liver cancer	0.000175	0.00021	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—F2—liver cancer	0.000174	0.000208	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CD—liver cancer	0.000173	0.000208	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PSMD10—liver cancer	0.000173	0.000207	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PSMA4—liver cancer	0.000173	0.000207	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTA1—liver cancer	0.000171	0.000205	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—F2—liver cancer	0.00017	0.000203	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NAT2—liver cancer	0.00017	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PSMA4—liver cancer	0.00017	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PSMD10—liver cancer	0.00017	0.000203	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CB—liver cancer	0.000166	0.000199	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CG—liver cancer	0.000166	0.000199	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF2—liver cancer	0.000166	0.000199	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CG—liver cancer	0.000163	0.000195	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDOB—liver cancer	0.000163	0.000195	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—KRAS—liver cancer	0.000162	0.000194	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—F2—liver cancer	0.000158	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CSF2—liver cancer	0.000155	0.000186	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CRABP1—liver cancer	0.000155	0.000186	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RAF1—liver cancer	0.000155	0.000185	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—F2—liver cancer	0.000154	0.000185	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—H2AFX—liver cancer	0.000153	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—liver cancer	0.000153	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CB—liver cancer	0.000151	0.000181	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CG—liver cancer	0.000151	0.000181	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PIK3CA—liver cancer	0.000149	0.000178	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CG—liver cancer	0.000148	0.000177	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	0.000146	0.000175	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—liver cancer	0.000144	0.000173	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CD—liver cancer	0.000143	0.000171	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—liver cancer	0.000139	0.000166	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TERT—liver cancer	0.000138	0.000166	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HRAS—liver cancer	0.000138	0.000165	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HPGDS—liver cancer	0.000136	0.000162	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCE—liver cancer	0.000134	0.000161	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PIK3CA—liver cancer	0.000133	0.00016	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CD—liver cancer	0.000133	0.000159	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—liver cancer	0.000132	0.000158	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCE—liver cancer	0.000131	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	0.00013	0.000155	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	0.000127	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF2—liver cancer	0.000127	0.000152	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KDR—liver cancer	0.000126	0.000151	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK14—liver cancer	0.000126	0.00015	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	0.000125	0.000149	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF2—liver cancer	0.000124	0.000149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—liver cancer	0.000123	0.000148	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—liver cancer	0.000122	0.000146	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—F2—liver cancer	0.000122	0.000146	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PSMD10—liver cancer	0.000121	0.000145	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PSMA4—liver cancer	0.000121	0.000145	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CSF2—liver cancer	0.000119	0.000142	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RAF1—liver cancer	0.000118	0.000142	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT2—liver cancer	0.000118	0.000141	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—H2AFX—liver cancer	0.000117	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—liver cancer	0.000117	0.00014	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APC—liver cancer	0.000116	0.000139	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CG—liver cancer	0.000116	0.000139	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CSF2—liver cancer	0.000116	0.000139	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RAF1—liver cancer	0.000116	0.000139	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CB—liver cancer	0.000116	0.000138	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CA—liver cancer	0.000115	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—H2AFX—liver cancer	0.000115	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—liver cancer	0.000114	0.000137	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	0.000113	0.000135	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2E1—liver cancer	0.000111	0.000132	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BRAF—liver cancer	0.00011	0.000131	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—liver cancer	0.000109	0.00013	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CA—liver cancer	0.000107	0.000129	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—liver cancer	0.000106	0.000127	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TERT—liver cancer	0.000106	0.000127	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—liver cancer	0.000104	0.000124	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TERT—liver cancer	0.000104	0.000124	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYCS—liver cancer	0.000103	0.000124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CD—liver cancer	0.000102	0.000123	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GGT1—liver cancer	0.000101	0.000121	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT1—liver cancer	0.000101	0.000121	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CA—liver cancer	0.000101	0.000121	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SERPINE1—liver cancer	0.000101	0.000121	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—KRAS—liver cancer	0.0001	0.00012	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KDR—liver cancer	9.68e-05	0.000116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK14—liver cancer	9.61e-05	0.000115	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KDR—liver cancer	9.47e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—liver cancer	9.43e-05	0.000113	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK14—liver cancer	9.41e-05	0.000113	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—liver cancer	9.38e-05	0.000112	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—F2—liver cancer	9.32e-05	0.000112	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—liver cancer	9.23e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CA—liver cancer	9.21e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RAF1—liver cancer	9.14e-05	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—F2—liver cancer	9.12e-05	0.000109	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTP1—liver cancer	9.11e-05	0.000109	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—liver cancer	8.99e-05	0.000108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CB—liver cancer	8.93e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MTOR—liver cancer	8.93e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APC—liver cancer	8.91e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CG—liver cancer	8.91e-05	0.000107	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—liver cancer	8.78e-05	0.000105	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APC—liver cancer	8.72e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CG—liver cancer	8.72e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HRAS—liver cancer	8.52e-05	0.000102	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BRAF—liver cancer	8.38e-05	0.0001	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN1B—liver cancer	8.38e-05	0.0001	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—liver cancer	8.38e-05	0.0001	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—liver cancer	8.29e-05	9.92e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CASP3—liver cancer	8.21e-05	9.83e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BRAF—liver cancer	8.2e-05	9.82e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—liver cancer	8.2e-05	9.81e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—liver cancer	8.16e-05	9.77e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCND1—liver cancer	7.99e-05	9.57e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JUN—liver cancer	7.98e-05	9.55e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP1A1—liver cancer	7.94e-05	9.5e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CTNNB1—liver cancer	7.91e-05	9.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CD—liver cancer	7.84e-05	9.38e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	7.76e-05	9.29e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—liver cancer	7.76e-05	9.29e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SERPINE1—liver cancer	7.75e-05	9.28e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN1A—liver cancer	7.73e-05	9.26e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—KRAS—liver cancer	7.67e-05	9.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CD—liver cancer	7.67e-05	9.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	7.6e-05	9.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SERPINE1—liver cancer	7.59e-05	9.08e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—liver cancer	7.55e-05	9.03e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—liver cancer	7.53e-05	9.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—KRAS—liver cancer	7.51e-05	8.99e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—liver cancer	7.4e-05	8.86e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARA—liver cancer	7.26e-05	8.69e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CA—liver cancer	7.05e-05	8.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RAF1—liver cancer	7e-05	8.38e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—liver cancer	6.97e-05	8.34e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT3—liver cancer	6.9e-05	8.26e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	6.9e-05	8.26e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RAF1—liver cancer	6.85e-05	8.2e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CB—liver cancer	6.83e-05	8.18e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MTOR—liver cancer	6.83e-05	8.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MTOR—liver cancer	6.69e-05	8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CB—liver cancer	6.69e-05	8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HRAS—liver cancer	6.52e-05	7.81e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN1B—liver cancer	6.41e-05	7.67e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MYC—liver cancer	6.41e-05	7.67e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—liver cancer	6.39e-05	7.66e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HRAS—liver cancer	6.38e-05	7.64e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—liver cancer	6.34e-05	7.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CASP3—liver cancer	6.28e-05	7.52e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN1B—liver cancer	6.27e-05	7.51e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—liver cancer	6.27e-05	7.51e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—liver cancer	6.24e-05	7.47e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CG—liver cancer	6.22e-05	7.45e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—liver cancer	6.21e-05	7.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CASP3—liver cancer	6.15e-05	7.36e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—liver cancer	6.14e-05	7.35e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCND1—liver cancer	6.12e-05	7.32e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—liver cancer	6.11e-05	7.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JUN—liver cancer	6.1e-05	7.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CTNNB1—liver cancer	6.06e-05	7.25e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—liver cancer	6e-05	7.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCND1—liver cancer	5.98e-05	7.17e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JUN—liver cancer	5.97e-05	7.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—liver cancer	5.94e-05	7.11e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CTNNB1—liver cancer	5.93e-05	7.1e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KRAS—liver cancer	5.92e-05	7.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN1A—liver cancer	5.92e-05	7.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—liver cancer	5.81e-05	6.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN1A—liver cancer	5.79e-05	6.93e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—liver cancer	5.77e-05	6.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—liver cancer	5.76e-05	6.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—liver cancer	5.65e-05	6.77e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—liver cancer	5.64e-05	6.75e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CD—liver cancer	5.47e-05	6.54e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CA—liver cancer	5.44e-05	6.51e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—liver cancer	5.4e-05	6.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—liver cancer	5.33e-05	6.38e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT3—liver cancer	5.28e-05	6.32e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—liver cancer	5.26e-05	6.3e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—liver cancer	5.22e-05	6.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT3—liver cancer	5.17e-05	6.19e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HRAS—liver cancer	5.03e-05	6.03e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MYC—liver cancer	4.91e-05	5.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—liver cancer	4.89e-05	5.86e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—liver cancer	4.82e-05	5.77e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MYC—liver cancer	4.8e-05	5.75e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—liver cancer	4.79e-05	5.73e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CB—liver cancer	4.77e-05	5.7e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KRAS—liver cancer	4.53e-05	5.43e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—liver cancer	4.45e-05	5.32e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KRAS—liver cancer	4.44e-05	5.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CA—liver cancer	4.16e-05	4.99e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CA—liver cancer	4.08e-05	4.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—liver cancer	4.03e-05	4.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—liver cancer	3.94e-05	4.72e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HRAS—liver cancer	3.85e-05	4.61e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HRAS—liver cancer	3.77e-05	4.51e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—liver cancer	3.69e-05	4.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—liver cancer	3.61e-05	4.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—liver cancer	3.4e-05	4.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—liver cancer	3.33e-05	3.99e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CA—liver cancer	2.9e-05	3.48e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—liver cancer	2.37e-05	2.84e-05	CbGpPWpGaD
